The guidance document “Medical Device
Accessories--Describing Accessories and Classification Mechanisms
for Accessory Types” encourages manufacturers and other parties to
utilize the “de novo request” process defined in section 513(f)(2)
of the FD&C Act to request risk-based classifications of new
types of medical device accessories. This process provides a
pathway to class I or class II classification for accessory devices
for which general controls, or general and special controls,
provide a reasonable assurance of safety and effectiveness, but for
which there is no legally marketed predicate device. Under the de
novo request process, manufacturers and other parties may submit a
de novo requesting that FDA make a classification determination for
the accessory device. The de novo must include a description of the
device and detailed information and reasons for any recommended
classification.
Our estimated burden for the
information collection reflects an overall decrease of 440 hours
and an increase of 17 responses. Factors contributing to the
revision of the burden estimate include the addition of the two new
accessory classification pathways crated by FDARA and the removal
of redundant burden described earlier in this document.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.